Company Profile
Becton Dickinson Stock Price, News & Analysis
- Ticker:
- BDX
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
177.07 USD (+3.76%)
Close
Last updated: August 6, 2026
39.8B USD
Market cap
Why the stock is moving
Following the latest company update, “BD Reports Third Quarter Fiscal 2026 Financial Results”, BDX closed up 3.76% at $177.07 on Aug 6, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Global Medical Technology
BD is a large medical-technology company supplying products used across medication delivery, connected care, biopharmaceutical manufacturing and interventional procedures.
Medical Essentials
The company manufactures needles, syringes, catheters, vascular-access products and other high-volume devices used throughout hospitals and outpatient care.
Connected Care and Biopharma Systems
BD provides infusion-management technology, medication-dispensing systems and drug-delivery components used by healthcare providers and pharmaceutical manufacturers.
Interventional Portfolio
Its interventional business includes products for peripheral intervention, surgery, urology and critical care. Following the separation of its former Biosciences and Diagnostic Solutions businesses, BD has a more focused pure-play medtech profile.
Future catalysts
Becton Dickinson’s catalysts are hospital-product demand, platform execution, and any margin or portfolio update that clarifies the company’s operating path. The market will care about steady execution more than a binary event.
Recent news
- 01
BD Reports Third Quarter Fiscal 2026 Financial Results
Source: Becton Dickinson
- 02
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
Source: Becton Dickinson
- 03
BD Board Declares Dividend
Source: Becton Dickinson
- 04
Mike Garrison to Retire from BD
Source: Becton Dickinson
- 05
BD to Announce Financial Results for its Third Quarter of Fiscal 2026
Source: Becton Dickinson
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Becton Dickinson (BDX)?
Becton Dickinson (BDX) most recently closed at 177.07 USD, a +3.76% move versus the previous session.
What is the market cap of Becton Dickinson (BDX)?
Becton Dickinson currently has a market capitalization of 39.8B USD on BioPharmSignal.
What does Becton Dickinson do?
Global Medical Technology BD is a large medical-technology company supplying products used across medication delivery, connected care, biopharmaceutical manufacturing and interventional procedures. Medical Essentials The company manufactures needles, syringes, catheters, vascular-access products and other high-volume devices used throughout hospitals and...
On which exchange is BDX stock listed?
Becton Dickinson (BDX) is associated with NYSE, United States, Biopharma.
What is Global?
Global Medical Technology BD is a large medical-technology company supplying products used across medication delivery, connected care, biopharmaceutical manufacturing and interventional procedures.
Which conditions is Becton Dickinson targeting with Global?
Global Medical Technology BD is a large medical-technology company supplying products used across medication delivery, connected care, biopharmaceutical manufacturing and interventional procedures. Medical Essentials The company manufactures needles, syringes, catheters, vascular-access products and other high-volume devices used throughout hospitals and...
How does Becton Dickinson describe recent progress with Global?
Becton Dickinson’s catalysts are hospital-product demand, platform execution, and any margin or portfolio update that clarifies the company’s operating path. The market will care about steady execution more than a binary event.
What is Medical?
Global Medical Technology BD is a large medical-technology company supplying products used across medication delivery, connected care, biopharmaceutical manufacturing and interventional procedures.